Increased competition from lower-priced offerings in the IVF industry have seen the Virtus Health share price almost halve.
James Carlisle is the head of research at Intelligent Investor (under AFSL 282288), owned by InvestSMART Group Limited. James has been researching stocks for more than two decades. After qualifying as a lawyer and working as a fund manager in London, James moved to Australia in 2002 and soon found Intelligent Investor. He covers the banking and financial services sectors. To unlock Intelligent Investor stock research and buy recommendations, take out a 15-day free membership.
The British bank CYBG, which demerged from NAB in 2016, has performed well – but so has its share price.
Commonwealth Bank’s recent media hammering over alleged infringements of money-laundering regulations has affected market value, but what does that mean for your shares?
Behind the themes expressed in the recently completed reporting season, one stood out: the incredible influence the bond market is having on share prices.